Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/1999
05/06/1999WO1999021824A1 Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
05/06/1999WO1999021617A2 Allosteric adenosine receptor modulators
05/06/1999WO1999021585A1 Pharmaceutical combination of a cyclooxigenase-2 inhibitor and acetaminophen or an opiate
05/06/1999WO1999021570A1 Citrus peel extract as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and preventive or treating agent for hepatic diseases
05/06/1999WO1999021568A1 Metal/thiol biocides
05/06/1999WO1999021566A1 Dietary composition with lipid binding properties for weight management and serum lipid reduction
05/06/1999WO1999021565A1 Nutritional supplement for cerebral metabolic insufficiencies
05/06/1999WO1999021564A1 Cyclic phosphonate ester inhibitors of microsomal triglyceride transfer protein and method
05/06/1999WO1999021563A1 Prevention of precipitated acute urinary retention
05/06/1999WO1999021562A1 Treatment of female sexual dysfunction
05/06/1999WO1999021561A1 Method for treatment of disorders of attention
05/06/1999WO1999021559A1 MORPHOLINO-N-ETHYL ESTER PRODRUGS OF INDOLE sPLA2 INHIBITORS
05/06/1999WO1999021558A2 Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
05/06/1999WO1999021557A1 Antagonists of gonadotropin releasing hormone
05/06/1999WO1999021556A1 Antihistamine/decongestant regimens for treating rhinitis
05/06/1999WO1999021555A2 Adenosine a3 receptor antagonists
05/06/1999WO1999021554A1 Antiulcerative
05/06/1999WO1999021553A1 Antagonists of gonadotropin releasing hormone
05/06/1999WO1999021552A1 Use of non-immunosuppressive compounds for promoting nerve regeneration
05/06/1999WO1999021551A1 Matrix for controlled delivery of highly soluble drugs
05/06/1999WO1999021550A1 Use of coumarin derivatives for the treatment of digestive tract disorders
05/06/1999WO1999021549A1 Hesperidin and hesperetin as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and preventive or treating agent for hepatic diseases
05/06/1999WO1999021548A1 Naringin and naringenin as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and preventive or treating agent for hepatic diseases
05/06/1999WO1999021547A1 Stable solution of zinc and bicarbonate ions
05/06/1999WO1999021546A1 N,N-DIETHYLGLYCOLAMIDO ESTER PRODRUGS OF INDOLE sPLA2 INHIBITORS
05/06/1999WO1999021544A1 Novel pharmaceutical alpha-keto carboxylic acid compositions, method of making and use thereof
05/06/1999WO1999021542A2 Methods for modulating macrophage proliferation using polyamine analogs
05/06/1999WO1999021541A2 Amelioration of ischemic damage using synthetic oxygen carriers
05/06/1999WO1999021540A2 Method of reducing craving in mammals
05/06/1999WO1999021539A1 Method for treating disease-related or drug-induced dyskinesias
05/06/1999WO1999021538A2 Use of glycosaminoglycans for producing pharmaceutical preparations for treating diabetes-associated diseases of the eye
05/06/1999WO1999021535A1 Osmotic medicament releasing system
05/06/1999WO1999021534A1 Solid state solutions and dispersions of poorly water soluble drugs
05/06/1999WO1999021531A1 β-D GLUCAN TOPICAL COMPOSITION
05/06/1999WO1999021530A1 Hair care composition
05/06/1999WO1999021512A1 Methods and pharmaceutical compositions for the closure of retinal breaks
05/06/1999WO1999021508A1 Administration of active agents, including 5-ht receptor agonists and antagonists, to treat premature ejaculation
05/06/1999WO1999021501A1 Spine distraction implant
05/06/1999WO1999021500A1 Spine distraction implant
05/06/1999WO1999021422A1 Treatment of schizophrenia with ampakines and neuroleptics
05/06/1999WO1999015493A8 9,10-dihydro-9,10-ethanoanthracene derivatives as phospholipase inhibitors
05/06/1999WO1999013920A3 Method for treating proliferative diseases by therapy
05/06/1999WO1999012549A3 Controlled release microsphere delivery system
05/06/1999WO1999011651A3 3-descladinose 6-o-substituded erythromycin derivatives
05/06/1999WO1999011252A3 N,n-bis (phenylcarbamoylmethyl) dimethylammonium chloride and derivatives in the treatment of pain
05/06/1999WO1999009156A3 Protease-related protein
05/06/1999WO1999009154A3 Novel hiv-specific synthetic oligonucleotides and methods of their use
05/06/1999WO1999009045A9 Antisense and antigene therapeutics with improved binding properties and methods for their use
05/06/1999WO1999008729A9 Loading and release of water-insoluble drugs
05/06/1999WO1999008667A3 Methods for treating physiological conditions associated with the use, or sequelae of use, of cocaine or other psychomotor stimulants
05/06/1999EP0913879A2 Improved terminal
05/06/1999EP0913481A2 Staphylococcus aureus member of the DEAD-type ATP-dependent RNA helicases (dbpB)
05/06/1999EP0913479A2 Adenine glycosylase
05/06/1999EP0913478A2 Histidine kinase from Streptococcus pneumoniae 0100993
05/06/1999EP0913477A2 LacC gene encoding a tagatose-6-phosphate kinase
05/06/1999EP0913476A2 Ornithine carbamoyl transferase sequence and uses thereof
05/06/1999EP0913474A2 Dbpa, a helicase from Staphylococcus aureus
05/06/1999EP0913472A2 Human LIG-1 Homolog (HLIG-1)
05/06/1999EP0913471A2 Cdna clone HNEAA81 that encodes a human 7-transmembrane receptor
05/06/1999EP0913396A2 Sulphonamide substituted benzopyran derivatives, process of preparation, their use as medicines and pharmaceutical compositions containing them
05/06/1999EP0913157A1 A new composite vaccine which contains antigen, antibody and recombinant dna and its preparing method
05/06/1999EP0913155A2 Pharmaceutical formulation for treating liver disorders
05/06/1999EP0913154A1 Antipsoriatic nail lacquer
05/06/1999EP0913153A1 Use of thiamines for the manufacture of a medicament to prevent and treat diabetic retinopathy and diabetic nephropathy
05/06/1999EP0913152A1 Stabilised combination of drugs comprising naloxone and an opioid analgesic
05/06/1999EP0913151A1 Anti-helicobacter pylori compositions containing 1-methylcarbapenem derivatives as the active ingredient
05/06/1999EP0913150A1 Combination of actives, viz. salicyl alcohol and fumaric acid and/or maleic acid, for the treatment of seborrheoic skin diseases, especially psoriasis
05/06/1999EP0912895A1 Method for monitoring t-cell reactivity
05/06/1999EP0912747A1 Aspartic protease
05/06/1999EP0912740A1 Rantes homolog from prostate
05/06/1999EP0912738A2 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
05/06/1999EP0912729A1 INHIBITION OF CHRONIC MYELOGENOUS LEUKEMIC CELL GROWTH BY LIPOSOMAL-ANTISENSE OLIGODEOXY-NUCLEOTIDES TARGETING TO Grb2 OR Crk1
05/06/1999EP0912728A1 Novel synthetic protein structural templates for the generation, screening and evolution of functional molecular surfaces
05/06/1999EP0912613A1 Synthetic polysaccharides, preparation method therefor and pharmaceutical compositions containing same
05/06/1999EP0912609A2 Fragments of leptin (ob protein)
05/06/1999EP0912608A2 Choline binding proteins for anti-pneumococcal vaccines
05/06/1999EP0912602A1 Method of treating beta-amyloid peptide associated conditions using trh
05/06/1999EP0912601A1 Suppression of immune response via inhibition of cathepsin s
05/06/1999EP0912600A2 Peptidomimetic inhibitors of cathepsin d and plasmepsins i and ii
05/06/1999EP0912598A1 Steroid bisphosphonates
05/06/1999EP0912592A1 Phosphotriester oligonucleotides, amidites and method of preparation
05/06/1999EP0912591A1 Novel method for isomerising the 10-methyl radical of erythromycin derivatives
05/06/1999EP0912584A2 New bis-platinum complexes with polyamine ligands as antitumor agents
05/06/1999EP0912579A1 Spiro-piperidine derivatives and their use as therapeutic agents
05/06/1999EP0912578A1 3-ureido-pyridofurans and -pyridothiophenes for the treatment of inflammatory processes
05/06/1999EP0912575A1 Improved methods for the synthesis of chemical compounds having pde-iv inhibitory activity
05/06/1999EP0912574A1 Beta-lactams
05/06/1999EP0912573A1 Camptothecin-skeleton compounds isolated from mappia foetida and the use thereof as syntones for novel medicaments as well as therapeutical agents
05/06/1999EP0912572A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
05/06/1999EP0912571A2 Naphthyridines which affect il-4 and g-csf
05/06/1999EP0912570A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
05/06/1999EP0912569A1 Preparation of (7s,trans)-2-(2-pyrimidinyl)-7-(hydroxymethyl)octahydro-2h-pyrido 1,2-a]pyrazine
05/06/1999EP0912568A1 Novel imidazopyridines
05/06/1999EP0912567A1 Carboline derivatives
05/06/1999EP0912563A1 Cinchonan based chiral selectors for separation of stereoisomers
05/06/1999EP0912561A1 3-phenyl-furan-(5h)-2-one and dihydrofuran-2-one derivatives as antibacterial agents
05/06/1999EP0912560A1 Indole derivatives for the treatment of osteoporosis
05/06/1999EP0912559A1 Fused heterocyclic compounds as protein tyrosine kinase inhibitors
05/06/1999EP0912558A1 Substituted indazole derivatives and their use as phosphodiesterase (pde) type iv and tumor necrosis factor (tnf) inhibitors
05/06/1999EP0912557A1 Oxindole derivatives
1 ... 6503 6504 6505 6506 6507 6508 6509 6510 6511 6512 6513 6514 6515 6516 6517 6518 6519 6520 6521 6522 6523 ... 7860